Strong Demand for Automated Analyzers Drives the Hematology Instruments and Reagents Market, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Hematology Instruments and Reagents markets. Global market for hematology instruments and reagents is projected to reach US$6.9 billion by 2020, driven by aging population, increasing prevalence of chronic conditions, trend towards early disease diagnosis, strong demand for automated and high-throughput analyzers, and increasing adoption of POC devices.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Hematology Instruments and Reagents: A Global Strategic Business Report

San Jose, California (PRWEB) June 24, 2014

Follow us on LinkedIn.

Hematology instruments and reagents are emerging as indispensable diagnostic tools used in testing, counting, measuring, and analyzing red blood cells, white blood cells, and platelets. In form factors ranging from compact handheld units, sophisticated POC instruments to complex and advanced laboratory analyzers, blood analyzers serve blood testing needs of various end-use markets such as research institutes, testing laboratories, and healthcare institutions. Hematology instruments have witnessed tremendous design transformations over the years, from traditional and simple manual red blood cell counters to present day sophisticated automated analyzers that provide quick, precise, and accurate analyses. Automation is a growing trend in the hematology instruments market. The market is witnessing a shift from manual testing to semi-automated analyzers and to fully-automated analyzers. Increasing labor shortage issues in developed markets, mounting costs, financial pressure and the need for quick analysis are driving demand for automation in hematology analysis.

Aging population and the ensuing increase in the number of individuals susceptible to age-related diseases represent the primary factor influencing market growth. The elderly, aged over 60 years, are prone to various chronic conditions that require therapeutic intervention, which in turn requires laboratory testing of various biological parameters. With the volume of procedures, increasing adoption of testing devices is also on the rise. Growth is also fueled by a number of other factors such as improvements in technology, incorporation of flow-cytometry technologies in hematology analyzers, launch of new products such as high throughput hematology analyzers and Point of Care (POC) devices, and rising adoption of automated hematology analyzers, among others.

The global coagulation analyzers market is driven by growing demand for clot busting products, blood-thinning therapeutics, as well as near patient testing products. Flagging systems such as platelet aggregates flags, blast flags, and infected RBC flags are also positively influencing growth in the market.

As stated by the new market research report on Hematology Instruments and Reagents, the United States represents the largest market worldwide. Economic uncertainty in Europe and the Affordable Care Act in the United States are negatively impacting growth patterns, with hospitals making cautious capital investments. Strong healthcare investments in developing countries like China and India are poised to spur future growth in the market. In-vitro diagnostics market in Brazil, China, and India is registering robust growth supported by growing population, economic development, increased healthcare spending, and higher affordability of private medical care services. Asia-Pacific is forecast to emerge as the fastest growing market worldwide, with a CAGR of 12.2% over the analysis period. Hematology/Coagulation reagents represents the largest and the fastest growing product market.

Major players covered in the report include Abbott Diagnostics Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Drucker Diagnostics, Horiba Ltd., Mindray Medical International Limited, Siemens Healthcare, Stago, and Sysmex Corporation among others.

The research report titled, "Hematology Instruments and Reagents: A Global Strategic Business Report," announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, and strategic industry activities of major companies worldwide. The report provides market estimates and projections in US dollars for all major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and the rest of Europe), Asia-Pacific (China, India, and the rest of Asia Pacific), Latin America, and the rest of the world. The report also analyzes the global market for Hematology Instruments and Reagents by product segment - Hematology/Coagulation Instruments (Hematology Analyzers, Hematology Flow Cytometers, Coagulation Analyzers, Hemoglobinometers, Slide Stainers, Hematology Centrifuges, and Hematology Vials), and Hematology/Coagulation Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents, Immuno-Hematology Reagents, Control Plasmas, and Hematology Stains).

For more details about this comprehensive market research report, please visit - http://www.strategyr.com/Hematology_Instruments_And_Reagents_Market_Report.asp.

About Global Industry Analysts, Inc.:

Global Industry Analysts, Inc. (GIA), is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends, while monitoring more than 126,000 companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/


Contact

  • Raghu Gopal
    Global Industry Analysts Inc
    +1 408-528-9966
    Email

Attachments